Humana (HUM) News
NYSE: HUMHealthcareHealthcare PlansUSD
396.51-7.76 (-1.92%)
At close: Oct 7, 4:02 PM ET · Delayed 15 min
After hours: 396.51 0.00%
HUM news summary
We found 20 recent headlines mentioning Humana (HUM): 6 in the past week and 13 in the past 30 days, most often from Nasdaq, Seeking Alpha. For price context, HUM is down 1.92% at $396.51. The most recent story, "Humana upgraded at Cantor on Medicare margin and STARS recovery", was published by Seeking Alpha on Oct 7, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Humana headlines
- Humana upgraded at Cantor on Medicare margin and STARS recoverySeeking Alpha
- UnitedHealth Q3 Coming Up: Two Questions Investors Can't IgnoreUNH heads into Q3 with investors focused on whether medical-cost gains can hold as Medicare Advantage margins improve without deeper member losses.NasdaqUNH, HUM, ELV
- Centene Narrows Medicare Advantage Footprint as Costs Remain ElevatedCNC is narrowing its 2027 Medicare Advantage footprint as elevated costs pressure plan economics, with a sharper focus on dual eligibles.NasdaqCNC, UNH, HUM
- UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost PressureUnitedHealth is exiting select Medicare Advantage plans for 2027 as rising medical costs pressure profitability, reshaping its membership mix.NasdaqUNH, HUM, CNC
- Noteworthy Thursday Option Activity: C, HUM, COSTLooking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Citigroup Inc (Symbol: C), where a total volume of 128,997 contracts has been traded…NasdaqC, HUM, COST
- Humana Expands Medicare Advantage Options For 2027; Stock Down(RTTNews) - Humana Inc. (HUM), a healthcare company, on Thursday said it is expanding its Medicare Advantage offerings for 2027, with plans featuring affordable premiums, $0 cost-sharing on eligible…Nasdaq
- Entergy Moves Up In Market Cap Rank, Passing HumanaIn the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Entergy Corp (Symbol: ETR) has taken over the #230 spot from Humana Inc. (Symbol: HUM),…NasdaqETR, HUM
- TempraMed Inks Distribution Agreement With Humana's CenterWell Pharmacy(RTTNews) - TempraMed Technologies Ltd. (VIVI.CN), a medical-technology company, announced it entered into a distribution agreement dated August 25, 2026, with CenterWell Pharmacy, Inc., the pharmacy…Nasdaq
- Noteworthy Wednesday Option Activity: MMM, HUM, WMTAmong the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in 3M Co (Symbol: MMM), where a total of 13,301 contracts have traded so far, representing…NasdaqMMM, HUM, WMT
- Can Cigna's AI Push Help Rein In Rising Healthcare Costs?CI is expanding AI across care coordination and specialty pharmacy as it seeks to manage elevated healthcare costs and improve access.NasdaqCI, UNH, HUM
- Can Centene Sustain Its Turnaround Amid Membership Pressure?CNC's profitability is recovering, but rising margins face a key test as Medicaid membership declines and eligibility reviews continue.NasdaqCNC, UNH, HUM
- UnitedHealth Reshapes Florida WellMed Operations With TPG DealUNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.NasdaqUNH, HUM, ELV
- BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?BrightSpring Health Services' Specialty and Infusion sales rose 30%, backed by LDD growth, new launches and expansion into rare therapies.NasdaqBTSG, HUM, CI
- UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.NasdaqUNH, HUM, ELV
- Is UnitedHealth Finally Turning the Corner After a Tough 2025?UNH is showing signs of recovery as medical costs improve, Optum gains momentum and 2026 earnings guidance rises.NasdaqUNH, HUM, ELV
- Humana Q2 Earnings Review: Management Tight-Lipped, But Recovery Still On TrackSeeking Alpha
- Humana Inc. (HUM) Q2 2026 Earnings Call TranscriptSeeking Alpha
- Humana: Q2 Earnings Must Catch Up With The StockSeeking Alpha
- Humana: Perhaps The 'Buy The Dip' Thesis Was Right All Along (Rating Upgrade)Seeking Alpha
- CVS Health Just Got a $13 Billion Reprieve. Here's Why the Stock Could Keep Climbing.Key PointsEarlier this year, CVS Health shares fell after reports that Medicare payment rates would only increase by 0.09% next year.NasdaqCVS, UNH, HUM, MFG